IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 165 filers reported holding IMPAX LABORATORIES INC in Q4 2013. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $8,000 | -50.0% | 618 | -11.2% | 0.00% | -100.0% |
| Q3 2016 | $16,000 | -23.8% | 696 | -5.9% | 0.00% | 0.0% |
| Q2 2016 | $21,000 | -12.5% | 740 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $24,000 | -20.0% | 740 | +6.3% | 0.00% | 0.0% |
| Q4 2015 | $30,000 | +20.0% | 696 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $25,000 | -50.0% | 696 | -36.4% | 0.00% | -50.0% |
| Q2 2015 | $50,000 | -7.4% | 1,094 | -5.8% | 0.00% | 0.0% |
| Q1 2015 | $54,000 | +38.5% | 1,161 | -6.0% | 0.00% | 0.0% |
| Q4 2014 | $39,000 | +14.7% | 1,235 | -13.9% | 0.00% | 0.0% |
| Q3 2014 | $34,000 | -20.9% | 1,435 | 0.0% | 0.00% | -33.3% |
| Q2 2014 | $43,000 | -48.8% | 1,435 | -55.2% | 0.01% | 0.0% |
| Q1 2014 | $84,000 | 0.0% | 3,202 | -3.9% | 0.01% | -53.8% |
| Q4 2013 | $84,000 | +42.4% | 3,331 | +12.1% | 0.01% | +8.3% |
| Q2 2013 | $59,000 | – | 2,972 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |